Targeting cyclin-dependent kinases for the treatment of pulmonary arterial hypertension

Pulmonary arterial hypertension (PAH) is a devastating disease with poor prognosis and limited therapeutic options. We screened for pathways that may be responsible for the abnormal phenotype of pulmonary arterial smooth muscle cells (PASMCs), a major contributor of PAH pathobiology, and identified...

Descripción completa

Detalles Bibliográficos
Autores principales: Weiss, Astrid, Neubauer, Moritz Christian, Yerabolu, Dinesh, Kojonazarov, Baktybek, Schlueter, Beate Christiane, Neubert, Lavinia, Jonigk, Danny, Baal, Nelli, Ruppert, Clemens, Dorfmuller, Peter, Pullamsetti, Soni Savai, Weissmann, Norbert, Ghofrani, Hossein-Ardeschir, Grimminger, Friedrich, Seeger, Werner, Schermuly, Ralph Theo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6525202/
https://www.ncbi.nlm.nih.gov/pubmed/31101827
http://dx.doi.org/10.1038/s41467-019-10135-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6525202/
https://www.ncbi.nlm.nih.gov/pubmed/31101827
http://dx.doi.org/10.1038/s41467-019-10135-x

Ejemplares similares